GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Immunotech Laboratories IMMB · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2009

Net income

−$977,570

FY2009FY2009

Free cash flow

—

FY2009FY2009

Shareholders' equity

$6.7m

FY2009FY2009

Income statement

Fiscal years

FY2009
Research and development$291,467
Operating income−$958,935
Net income−$977,570
Diluted earnings per share-23.33

Balance sheet

At each fiscal year end

FY2009
Total assets$10.5m
Total liabilities$3.7m
Debt$2.4m
Shareholders' equity$6.7m
Shares outstanding0m

Cash flow

Fiscal years

Latest quarters

By quarter end

Sept 2006Jun 2006Mar 2006Dec 2005Sept 2005Dec 2004Sept 2004Jun 2004
Revenue——$4,000—————
Gross profit——$4,000—————
Operating income−$146,000−$798,000−$4.3m−$1.8m−$261,000−$30,000−$40,000−$10,000
Net income−$152,000−$93,000−$39.4m−$1.7m−$31.9m−$30,000−$40,000−$20,000
Diluted earnings per share-0.57-0.35-209.19-11.60-1,942.75-12.66-13.66-7.02
Total assets$383,000$266,000$254,000$50,000$17,000———
Cash and short-term investments$19,000$15,000$13,000$47,000$8,000———
Debt$484,000$495,000$1.1m$405,000—$80,000$320,000$320,000
Shareholders' equity−$2.1m−$2.0m−$2.2m−$1.1m−$781,000−$630,000−$670,000−$640,000

Growth per year

Compound annual rate

3 years5 years10 years
Operating income17.8%5.8%—
Net income16.7%5.4%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%500%100%237210%66567%0%0%-33%-10%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 26 Feb 2009
  • 200-to-1 reverse split · 29 Aug 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.